Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML

Open access
Li, Zejuan, Huang, Hao, Li, Yuanyuan, Jiang, Xi, Chen, Ping, Arnovitz, Stephen, Radmacher, Michael D., Maharry, Kati, Elkahloun, Abdel, Yang, Xinan, He, Chunjiang, He, Miao, Zhang, Zhiyu, Dohner, Konstanze, Neilly, Mary Beth, Price, Colles, Lussier, Yves A., Zhang, Yanming, Larson, Richard A., Le Beau, Michelle M., Caligiuri, Michael A., Bullinger, Lars, Valk, Peter J. M., Delwel, Ruud, Lowenberg, Bob, Liu, Paul P., Marcucci, Guido, Bloomfield, Clara D., Rowley, Janet D., Chen, Jianjun·2012·Blood

Abstract

Increased expression levels of miR-181 family members have been shown to be associated with favorable outcome in patients with cytogenetically normal acute myeloid leukemia. Here we show that increased expression of miR-181a and miR-181b is also significantly (P < .05; Cox regression) associated with favorable overall survival in cytogenetically abnormal AML (CA-AML) patients. We further show that up-regulation of a gene signature composed of 4 potential miR-181 targets (including HOXA7, HOXA9, HOXA11, and PBX3), associated with down-regulation of miR-181 family members, is an independent predictor of adverse overall survival on multivariable testing in analysis of 183 CA-AML patients. The independent prognostic impact of this 4-homeobox-gene signature was confirmed in a validation set of 271 CA-AML patients. Furthermore, our in vitro and in vivo studies indicated that ectopic expression of miR-181b significantly promoted apoptosis and inhibited viability/proliferation of leukemic cells and delayed leukemogenesis; such effects could be reversed by forced expression of PBX3. Thus, the up-regulation of the 4 homeobox genes resulting from the down-regulation of miR-181 family members probably contribute to the poor prognosis of patients with nonfavorable CA-AML. Restoring expression of miR-181b and/or targeting the HOXA/PBX3 pathways may provide new strategies to improve survival substantially.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2011-10-386235

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 160

Metadata

Authors
Li, Z., Huang, H., Li, Y., Jiang, X., Chen, P., Arnovitz, S., Radmacher, M. D., Maharry, K., Elkahloun, A., Yang, X., He, C., He, M., Zhang, Z., Dohner, K., Neilly, M. B., Price, C., Lussier, Y. A., Zhang, Y., Larson, R. A., Le Beau, M. M., Caligiuri, M. A., Bullinger, L., Valk, P. J. M., Delwel, R., Lowenberg, B., Liu, P. P., Marcucci, G., Bloomfield, C. D., Rowley, J. D., & Chen, J.
Venue
Blood
Published
2012-03-08
Volume
119
Issue
10
Pages
2314-2324
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2006131936
Cited by
160
References
3
FWCI
14.40
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. https://app.cochat.ai/papers/10.1182/blood-2011-10-386235
The paper
Li, Z., Huang, H., Li, Y., Jiang, X., Chen, P., Arnovitz, S., Radmacher, M. D., Maharry, K., Elkahloun, A., Yang, X., He, C., He, M., Zhang, Z., Dohner, K., Neilly, M. B., Price, C., Lussier, Y. A., Zhang, Y., Larson, R. A., . . . Chen, J. (2012). Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood. https://doi.org/10.1182/blood-2011-10-386235

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.